{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:21:05Z","timestamp":1767172865413,"version":"3.48.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.7759\/cureus.100469","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:16:11Z","timestamp":1767172571000},"source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and Safety of Mefenamic Acid Oral Suspension in Pediatric Practice for Febrile Illness: An Observational Study (EASE-O-MAPP Study)"],"prefix":"10.7759","author":[{"given":"Vasant","family":"Khalatkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhu N","family":"Kasture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-92336-9_3","article-title":"Pathogenesis of fever","author":"El-Radhi AS","year":"2019","unstructured":"El-Radhi AS. Pathogenesis of fever. Clinical Manual of Fever in Children. Springer Nature, 2019. 53-68. 10.1007\/978-3-319-92336-9_3"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2592793","article-title":"Optimizing pharmacological management of the febrile child","volume":"26","author":"Bianchi M","year":"2025","unstructured":"Bianchi M, Costa M, Cardinale F, et al.. Optimizing pharmacological management of the febrile child. Expert Opin Pharmacother. 2025, 26:1-15. 10.1080\/14656566.2025.2592793","journal-title":"Expert Opin Pharmacother"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)26444-8","article-title":"Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-xylyl)anthranilic acid (mefenamic acid)","volume":"138","author":"Winder CV","year":"1962","unstructured":"Winder CV, Wax J, Scotti L, Scherrer RA, Jones EM, Short FW. Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-xylyl)anthranilic acid (mefenamic acid). J Pharmacol Exp Ther. 1962, 138:405-13.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref4","article-title":"Mefenamic acid: the evolution of a versatile NSAID","volume":"32","author":"Tripathi SK","year":"2021","unstructured":"Tripathi SK, Kasture PN. Mefenamic acid: the evolution of a versatile NSAID. Indian J Clin Pract. 2021, 32:115-23.","journal-title":"Indian J Clin Pract"},{"key":"ref5","article-title":"Inflammasome, inflammation, infection and mefenamic acid","volume":"70","author":"Kasture P","year":"2022","unstructured":"Kasture P, Mehta K, Gowda A. Inflammasome, inflammation, infection and mefenamic acid. J Assoc Physicians India. 2022, 70:11-2.","journal-title":"J Assoc Physicians India"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.88412","article-title":"Consensus on the use of mefenamic acid in pediatric practice (MAPP): perspectives from Indian pediatricians","volume":"17","author":"Pai U","year":"2025","unstructured":"Pai U, Venkata RA, Shah A, et al.. Consensus on the use of mefenamic acid in pediatric practice (MAPP): perspectives from Indian pediatricians. Cureus. 2025, 17:e88412. 10.7759\/cureus.88412","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26733","article-title":"The antipyretic effect of high-dose Paracetamol versus mefenamic acid in the treatment of febrile children: a randomized control trial","volume":"14","author":"Loya A","year":"2022","unstructured":"Loya A, Siddiqui MS, Sangle A, Ingale V, Saha S, Nelanuthala M. The antipyretic effect of high-dose Paracetamol versus mefenamic acid in the treatment of febrile children: a randomized control trial. Cureus. 2022, 14:e26733. 10.7759\/cureus.26733","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181962ad5","article-title":"Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods","volume":"37","author":"Polderman KH","year":"2009","unstructured":"Polderman KH, Herold I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med. 2009, 37:1101-20. 10.1097\/CCM.0b013e3181962ad5","journal-title":"Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/2050312120928732","article-title":"Intensive fever control using a therapeutic normothermia protocol in patients with febrile early septic shock: a randomized feasibility trial and exploration of the immunomodulatory effects","volume":"8","author":"Saoraya J","year":"2020","unstructured":"Saoraya J, Musikatavorn K, Puttaphaisan P, Komindr A, Srisawat N. Intensive fever control using a therapeutic normothermia protocol in patients with febrile early septic shock: a randomized feasibility trial and exploration of the immunomodulatory effects. SAGE Open Med. 2020, 8:8732. 10.1177\/2050312120928732","journal-title":"SAGE Open Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2019.12.013","article-title":"Increased levels of NLRP3 in children with febrile seizures","volume":"42","author":"Liu Z","year":"2020","unstructured":"Liu Z, Xian H, Ye X, Chen J, Ma Y, Huang W. Increased levels of NLRP3 in children with febrile seizures. Brain Dev. 2020, 42:336-41. 10.1016\/j.braindev.2019.12.013","journal-title":"Brain Dev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-04533-4","article-title":"Increased expression of NLRP3 associated with elevated levels of HMGB1 in children with febrile seizures: a case-control study","volume":"24","author":"Ye XG","year":"2024","unstructured":"Ye XG, She FZ, Yu DN, et al.. Increased expression of NLRP3 associated with elevated levels of HMGB1 in children with febrile seizures: a case-control study. BMC Pediatr. 2024, 24:44. 10.1186\/s12887-024-04533-4","journal-title":"BMC Pediatr"},{"key":"ref12","article-title":"Pyrogenic cytokines mediated pathophysiology of fever and role of mefenamic acid in pediatric practice","volume":"32","author":"Gambhir A","year":"2021","unstructured":"Gambhir A, Tamboli S, Prasad SM, Inamdar NR. Pyrogenic cytokines mediated pathophysiology of fever and role of mefenamic acid in pediatric practice. Indian J Clin Pract. 2021, 32:229-36.","journal-title":"Indian J Clin Pract"},{"key":"ref13","article-title":"Improve cognitive impairment using mefenamic acid non-steroidal anti-inflammatory therapy: additional beneficial effect found in a controlled clinical trial for prostate cancer therapy","volume":"13","author":"Melnikov V","year":"2021","unstructured":"Melnikov V, Tiburcio-Jimenez D, Mendoza-Hernandez MA, et al.. Improve cognitive impairment using mefenamic acid non-steroidal anti-inflammatory therapy: additional beneficial effect found in a controlled clinical trial for prostate cancer therapy. Am J Transl Res. 2021, 13:4535-43.","journal-title":"Am J Transl Res"},{"key":"ref14","article-title":"Randomized open-label study to compare the safety and efficacy of paracetamol, ibuprofen, and mefenamic acid in febrile children","volume":"8","author":"Reddy GT","year":"2020","unstructured":"Reddy GT, Gobbur RH, Patil SV. Randomized open-label study to compare the safety and efficacy of paracetamol, ibuprofen, and mefenamic acid in febrile children. Int J Sci Study. 2020, 8:58-62.","journal-title":"Int J Sci Study"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102240","article-title":"Interpreting the benefit and risk data in between-drug comparisons: illustration of the challenges using the example of mefenamic acid versus ibuprofen","volume":"14","author":"Farkouh A","year":"2022","unstructured":"Farkouh A, Hemetsberger M, Noe CR, Baumg\u00e4rtel C. Interpreting the benefit and risk data in between-drug comparisons: illustration of the challenges using the example of mefenamic acid versus ibuprofen. Pharmaceutics. 2022, 14:2240. 10.3390\/pharmaceutics14102240","journal-title":"Pharmaceutics"},{"key":"ref16","article-title":"Choice of antipyretic in children","volume":"43","author":"Khubchandani RP","year":"1995","unstructured":"Khubchandani RP, Ghatikar KN, Keny S, Usgaonkar NG. Choice of antipyretic in children. J Assoc Physicians India. 1995, 43:614-6.","journal-title":"J Assoc Physicians India"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-022-00514-1","article-title":"Efficacy and safety of NSAIDs in infants: a comprehensive review of the literature of the past 20 years","volume":"24","author":"Ziesenitz VC","year":"2022","unstructured":"Ziesenitz VC, Welzel T, van Dyk M, Saur P, Gorenflo M, van den Anker JN. Efficacy and safety of NSAIDs in infants: a comprehensive review of the literature of the past 20 years. Paediatr Drugs. 2022, 24:603-55. 10.1007\/s40272-022-00514-1","journal-title":"Paediatr Drugs"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225010-00001","article-title":"Unlicensed and off-label drug use in children: implications for safety","volume":"25","author":"Choonara I","year":"2002","unstructured":"Choonara I, Conroy S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf. 2002, 25:1-5. 10.2165\/00002018-200225010-00001","journal-title":"Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439109-effectiveness-and-safety-of-mefenamic-acid-oral-suspension-in-pediatric-practice-for-febrile-illness-an-observational-study-ease-o-mapp-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:16:13Z","timestamp":1767172573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439109-effectiveness-and-safety-of-mefenamic-acid-oral-suspension-in-pediatric-practice-for-febrile-illness-an-observational-study-ease-o-mapp-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.100469","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}